Home › Leukemia › Virginia › Charlottesville
Leukemia clinical trials in Charlottesville, VA
5 studies for Leukemia are looking for participants at sites in and around Charlottesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RecruitingPhase 3
- Quetzal Site 3, Charlottesville
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- University of Virginia Comprehensive Cancer Center, Charlottesville
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- University of Virginia School of Medicine, Charlottesville
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
RecruitingPhase 1/2
- Dren Investigational Site, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Charlottesville
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX28 studies
- Boston, MA25 studies
- New York City, NY19 studies
- Los Angeles, CA16 studies
- Chicago, IL16 studies
- Durham, NC13 studies
- Philadelphia, PA12 studies
- Columbus, OH12 studies
- Nashville, TN12 studies
- Baldwin Park, CA12 studies
- Milwaukee, WI11 studies
- Seattle, WA11 studies
Other studies in Charlottesville
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia17 studies
- Prostate Cancer15 studies
- Cancer (all types)14 studies
- Endometrial Cancer14 studies
- Metastatic Cancer13 studies
- Lung Cancer13 studies
- Heart Failure11 studies
- Ischemic Stroke10 studies
- Ovarian Cancer10 studies
- Colorectal Cancer10 studies
- Obesity9 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.